KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 133 filers reported holding KARUNA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 3.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,500 | -31.6% | 73,922 | -12.3% | 0.01% | -33.3% |
| Q2 2023 | $18,283 | +115.5% | 84,316 | +80.5% | 0.01% | +200.0% |
| Q1 2023 | $8,484 | +46.6% | 46,709 | +58.6% | 0.00% | +33.3% |
| Q4 2022 | $5,786 | -99.9% | 29,445 | -5.3% | 0.00% | -62.5% |
| Q3 2022 | $6,994,000 | +2185.6% | 31,098 | +1187.2% | 0.01% | – |
| Q2 2022 | $306,000 | -75.6% | 2,416 | -75.6% | 0.00% | -100.0% |
| Q1 2022 | $1,256,000 | -88.2% | 9,909 | -87.8% | 0.00% | -50.0% |
| Q4 2021 | $10,618,000 | +357.9% | 81,056 | +327.7% | 0.00% | +100.0% |
| Q3 2021 | $2,319,000 | +17.0% | 18,953 | +9.1% | 0.00% | 0.0% |
| Q2 2021 | $1,982,000 | -45.6% | 17,373 | -42.7% | 0.00% | -50.0% |
| Q1 2021 | $3,642,000 | -12.0% | 30,303 | -25.6% | 0.00% | 0.0% |
| Q4 2020 | $4,137,000 | +549.5% | 40,723 | +393.8% | 0.00% | – |
| Q3 2020 | $637,000 | -38.5% | 8,247 | -11.3% | 0.00% | -100.0% |
| Q2 2020 | $1,035,000 | +277.7% | 9,295 | +144.7% | 0.00% | – |
| Q1 2020 | $274,000 | -29.2% | 3,799 | -26.0% | 0.00% | – |
| Q4 2019 | $387,000 | +945.9% | 5,137 | +127.5% | 0.00% | – |
| Q3 2019 | $37,000 | – | 2,258 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |